ARA-290
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ARA-290, covering 2015-09-03 to 2024-10-04. Get the full timeline:
Most recent: Clinical Trial Update: The Use of ARA290 for the Treatment of Diabetic Macular Oedema [Phase 2]